Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024.
Attorney General Ken Paxton alleges Pfizer also attempted to silence critics of its vaccine.
When it comes to winning investment strategies, buying dividend stocks tends to rise to the top. It's likely because these are successful, profitable companies that have been battle-tested over time a
Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?
The one thing that experts, along with vaccine makers, can agree on is that low vaccination rates put people at risk of getting severe Covid infections.
As demand for novel IBD treatments rises, investment in this dynamic sector could be rewarding. Some of the key players in the market are AbbVie (ABBV), J&J (JNJ), Lilly (LLY) and Pfizer (PFE).

How to earn $500 a month from this stock?

07:32am, Wednesday, 29'th Nov 2023
Pfizer's (NASDAQ: PFE) stock continued its 11-month decline in November after its third-quarter sales missed expectations amid waning demand for Covid products.
Some of the stocks dumped as funds do tax-loss selling can be attractive buys.
Pfizer Inc. (NYSE:PFE ) 6th Annual Evercore ISI HealthCONx Conference November 28, 2023 10:50 AM ET Company Participants Dave Denton - CFO and EVP Conference Call Participants Umer Raffat - Evercore I
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
The stock market is enjoying some holiday cheer. Amid signs that inflation is letting up and the Federal Reserve may finally put an end to its rate hikes, traders are piling into all sorts of investme
The second half of November saw announcements of annual dividend increases from nine companies, including an 11% increase from Nike. Merck's annual dividend boost will be deferred to December. Widely-
While Pfizer (NYSE: PFE) surged and became a household name during the COVID-19 pandemic due to the demand for its vaccines, the company has been on a decisive downward trajectory ever since.
Weight loss drugs have been at the heart of Eli Lilly and Novo Nordisk's market-beating performances this year. Pfizer is also developing a weight loss candidate that has been billed as a potential me
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE